It’s not just Depo-Provera — study links 5 more birth control drugs to brain tumor risk
New York Post
Last updated: July 13, 2026
A recent study has revealed a significant link between the use of hormonal birth control drugs and an increased risk of developing meningiomas, a type of brain tumor. This risk extends beyond Depo-Provera to include at least five other commonly used hormonal contraceptives.
- Hormonal birth control methods, including injections, pills, implants, and vaginal rings, have been associated with a higher likelihood of developing meningiomas. These tumors are typically slow-growing and often benign, but their increased incidence in users of hormonal contraceptives warrants attention.
- The study identified several specific hormonal birth control drugs, in addition to Depo-Provera, that contribute to this elevated risk. While the exact biological mechanisms are still under investigation, the research highlights a potential health concern for a large population of women.
- Meningiomas arise from the meninges, the membranes that surround the brain and spinal cord. Although generally not cancerous, their growth can lead to serious neurological issues if they press on vital brain structures.
- The findings underscore the importance of informed consent and patient-doctor communication regarding the potential risks associated with long-term use of hormonal birth control. Further research may be needed to fully understand the implications and explore alternative contraceptive options for women concerned about this risk.
